Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Charles Gleason

1PUBLICATIONS

19CO-AUTHORS

Nanoelectronics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 15, 2023

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.

Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh

Pageof 1

Frequent Collaborators

1 joint publications

Juan Manuel Carreño

1 joint publications

Ariel Raskin

1 joint publications

Gagandeep Singh

1 joint publications

Johnstone Tcheou

1 joint publications

Hisaaki Kawabata

1 joint publications

Vladimir Vigdorovich

1 joint publications

Irene González Domínguez

1 joint publications

Jose Luis Martinez

1 joint publications

Stefan Slamanig

1 joint publications

D Noah Sather

Frequent Collaborators

1 joint publications

Juan Manuel Carreño

1 joint publications

Ariel Raskin

1 joint publications

Gagandeep Singh

1 joint publications

Johnstone Tcheou

Top Related Videos

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

See more related videos

Top Related Videos

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

See more related videos